<DOC>
	<DOCNO>NCT01634529</DOCNO>
	<brief_summary>The purpose study investigate whether V158866 safe give healthy male subject single multiple dos .</brief_summary>
	<brief_title>Single Multiple Ascending Dose Study V158866 Healthy Volunteers</brief_title>
	<detailed_description>A first human study : To evaluate safety tolerability single multiple dos V158866 healthy male subject To assess pharmacokinetics ( PK ) V158866 healthy male subject To assess pharmacodynamics ( PD ) V158866 determine whether V158866 inhibits fatty acid amide hydrolase ( FAAH ) healthy male subject</detailed_description>
	<criteria>Subjects must : healthy male subject age 18 45 year inclusive Have body mass index ( BMI ) 19 30 kg/m2 inclusive able provide semen sample willing use effective method contraception ( see Section 6.1 ) duration study 4 month last dose study medication able comply requirement entire study give write informed consent Subjects must : intend father child female partner sperm donation within 4 month last dose study medication vasectomy significant medical condition history condition Investigator considers exclude subject study multiple drug allergy allergic component V158866 study medication match placebo ( see Section 7 ) smoke 5 cigarette per day 6 calendar month study drug administration consume 28 unit alcohol per week , significant history alcohol abuse positive test alcohol drug abuse screen admission dose session donate blood plasma excess 500 mL within 4 month study drug administration expose new investigational agent within 3 month study drug administration clinically relevant abnormal finding vital sign clinically significant abnormality laboratory screen test clinically relevant abnormal physical finding examination clinically relevant abnormal finding 12lead ECG mean QTc correct use Bazett 's correction ( QTcB ) screen &gt; 430 msec ( 3 supine ECGs , perform least 5 minute apart ) seropositive hepatitis B , hepatitis C HIV viruses screen medical social reason participate study raise General Practitioner/primary care physician condition might increase risk individual decrease chance obtain satisfactory data , assess Investigator treatment prescription medicine within one month overthecounter medicine , except paracetamol , within one week study drug administration</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>